New Patent is Added to the Company's Portfolio of
Formulations that Rapidly Reduce Blood Alcohol Content
JUPITER,
Fla., Sept. 6, 2024 /PRNewswire/ -- Safety Shot,
Inc. (Nasdaq: SHOT) ("Safety Shot" or "the Company"), a wellness
company behind the world's first rapid alcohol reducer that lowers
blood alcohol content ("BAC") by supporting its metabolism in as
little as 30 minutes, has announced the Notice of Allowance of for
a U.S. patent that covers its newest clinically-backed formula.
"This latest patent marks a significant milestone in Safety
Shot's quest to lead a brand-new category that the Company has
created to solve alcohol related problems," stated Safety Shot COO
and co-owner of the patent, David
Sandler.
The Company's family of patents aims to corroborate Safety
Shot's competitive advantage in the market which includes being
faster at removing alcohol, improving cognitive ability, and
reducing impairment by supporting the metabolism of alcohol.
The latest patent continues to advance an exciting new category of
functionality.
"The patent locks up our IP and further separates us from the
pack as the only the group that has been able prove that Safety's
Shot revolutionary formula can dramatically reduce blood alcohol
and reduce the build-up toxins associated with alcohol consumption
rapidly. This patent helps solidify Safety Shot as the
uncontested world leader in making people feel better faster,"
continued Sandler, who co-invented the Safety Shot wellness
product.
"The patent allows Safety Shot to exercise authority over
specific claims in the marketplace. It further proves our
commitment to finding solutions for consumers while taking a hard
stance against other companies that enter the category with
inferior products. Our patents provide enforceable support to our
industry-leading clinical findings," noted Safety Shot CEO and
patent co-owner, Jarret Boon.
As part of the Company's efforts to be recognized as the world
leader in combating the ill effects of alcohol, the team at Safety
Shot is committed to advancing its science through its robust
R&D platform that offers a variety of formats using its
clinically proven, patented formula.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company,
has developed Safety Shot, the first patented wellness product on
Earth that lowers blood alcohol content by supporting its
metabolism, while boosting clarity, energy, and overall mood.
Safety Shot is available for purchase online at
DrinkSafetyShot.com and Amazon. The Company is
introducing business-to-business sales of Safety Shot to
distributors, retailers, restaurants, and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 about us and our industry
that involve substantial risks and uncertainties. All statements
other than statements of historical facts contained in this press
release, including statements regarding Safety Shot's ability to
develop and commercialize a product that lowers blood alcohol
content, the timing, progress and results of non-clinical studies
and clinical trials, including our product development plans and
strategies, Safety Shot's future results of operations or financial
condition, business strategy and plans, and objectives of
management for future operations, are forward-looking statements.
In some cases, you can identify forward-looking statements because
they contain words such as "anticipate," "believe," "contemplate,"
"continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will," or
"would" or the negative of these words or other similar terms or
expressions. Forward-looking statements are based on Safety Shot's
current expectations and are subject to inherent uncertainties,
risks and assumptions that are difficult to predict. Factors that
could cause actual results to differ include, but are not limited
to, our ability to comply with applicable U.S. and foreign laws,
rules, and regulations, product liability claims, our ability to
develop and market Safety Shot and the risks and uncertainties that
are described more fully in the section titled "Risk Factors" in
Safety Shot's Form 10-Q for the fiscal year ended June 30, 2024, filed with the Securities and
Exchange Commission on August 15,
2024, and its other filings with the Securities and Exchange
Commission. Forward-looking statements contained in this press
release are made as of this date, and Safety Shot undertakes no
duty to update such information except as required under applicable
law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/safety-shot-announces-notice-of-allowance-for-new-patent-to-secure-ip-and-enforce-clinically-backed-claims-302240640.html
SOURCE Safety Shot